Company / SG&A per Share
Biohaven Ltd. SG&A per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.98
FY2024
5-year range
$0.41 / $2.92
FY2020-FY2024
Trend
+11.0%
vs FY2023
Sector context
#125 of 210
Health Care
What the data says
At $0.98, Biohaven Ltd.'s sg&a per share ranks #86 of 210 in the Health Care sector. Improved from $2.92 to $0.98 over the past 2 years.
Based on SEC 10-K filings.
0.98 in FY2024 with a 3-year CAGR of +1.0%.
Improved from $2.92 to $0.98 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +1.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#86 of 210 in Health CareTop 40% of 210This company $0.98 Sector average $29.50
▼
-96.7% below sector average
Key checks
Key Insights
- In FY2024, sg&a per share increased 11.0% year-over-year.
- Ranks #125 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2022.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.98 | +11.0% |
| FY2023 | $0.88 | -69.9% |
| FY2022 | $2.92 | +207.8% |
| FY2021 | $0.95 | +133.2% |
| FY2020 | $0.41 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026